DOCSLIB.ORG

Federal Register/Vol. 84, No. 26/Thursday, February 7, 2019/Notices

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Federal Register/Vol. 84, No. 26/Thursday, February 7, 2019/Notices 2570 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices National Fire Protection Association Register pursuant to Section 6(b) of the Morrissette Drive, Springfield, Virginia (‘‘NFPA’’) has filed written notifications Act on October 22, 2018 (83 FR 53297). 22152. simultaneously with the Attorney Suzanne Morris, SUPPLEMENTARY INFORMATION: General and the Federal Trade The Commission disclosing additions or Chief, Premerger and Division Statistics Unit, Attorney General has delegated his changes to its standards development Antitrust Division. authority under the Controlled activities. The notifications were filed [FR Doc. 2019–01489 Filed 2–6–19; 8:45 am] Substances Act to the Administrator of for the purpose of extending the Act’s BILLING CODE 4410–11–P the Drug Enforcement Administration provisions limiting the recovery of (DEA), 28 CFR 0.100(b). Authority to antitrust plaintiffs to actual damages exercise all necessary functions with under specified circumstances. DEPARTMENT OF JUSTICE respect to the promulgation and implementation of 21 CFR part 1301, Specifically, NFPA has provided an Drug Enforcement Administration updated and current list of its standards incident to the registration of development activities, related technical [Docket No. DEA–392] manufacturers, distributors, dispensers, committee and conformity assessment importers, and exporters of controlled activities. Information concerning NFPA Bulk Manufacturer of Controlled substances (other than final orders in regulations, technical committees, Substances Application: IsoSciences, connection with suspension, denial, or current standards, standards LLC revocation of registration) has been development and conformity redelegated to the Assistant assessment activities are publicly ACTION: Notice of application. Administrator of the DEA Diversion available at nfpa.org. Control Division (‘‘Assistant On September 20, 2004, NFPA filed DATES: Registered bulk manufacturers of Administrator’’) pursuant to section 7 of its original notification pursuant to the affected basic classes, and 28 CFR part 0, appendix to subpart R. Section 6(a) of the Act. The Department applicants therefore, may file written In accordance with 21 CFR of Justice published a notice in the comments on or objections to the 1301.33(a), this is notice that on Federal Register pursuant to Section issuance of the proposed registration on November 1, 2017, IsoSciences, LLC, 6(b) of the Act on October 21, 2004 (69 or before April 8, 2019. 340 Mathers Road, Ambler, FR 61869). ADDRESSES: Written comments should Pennsylvania 19002, applied to be The last notification was filed with be sent to: Drug Enforcement registered as a bulk manufacturer of the the Department on October 10, 2018. A Administration, Attention: DEA Federal following basic classes of controlled notice was published in the Federal Register Representative/DPW, 8701 substances: Drug Controlled substance code Schedule Cathinone ................................................................................................................................................................................ 1235 I Methcathinone ......................................................................................................................................................................... 1237 I Lysergic acid diethylamide ...................................................................................................................................................... 7315 I Marihuana ................................................................................................................................................................................ 7360 I Tetrahydrocannabinols ............................................................................................................................................................ 7370 I 3,4-Methylenedioxyamphetamine ............................................................................................................................................ 7400 I 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................... 7404 I 5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................................ 7431 I Alpha-methyltryptamine ........................................................................................................................................................... 7432 I Bufotenine ................................................................................................................................................................................ 7433 I Diethyltryptamine ..................................................................................................................................................................... 7434 I Dimethyltryptamine .................................................................................................................................................................. 7435 I Psilocybin ................................................................................................................................................................................. 7437 I Psilocyn ................................................................................................................................................................................... 7438 I 5-Methoxy-N,N-diisopropyltryptamine ..................................................................................................................................... 7439 I Dihydromorphine ..................................................................................................................................................................... 9145 I Heroin ...................................................................................................................................................................................... 9200 I Nicocodeine ............................................................................................................................................................................. 9309 I Nicomorphine ........................................................................................................................................................................... 9312 I Normorphine ............................................................................................................................................................................ 9313 I Thebacon ................................................................................................................................................................................. 9315 I Normethadone ......................................................................................................................................................................... 9635 I Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ......................................................................................... 9811 I Para-Fluorofentanyl ................................................................................................................................................................. 9812 I 3-Methylfentanyl ...................................................................................................................................................................... 9813 I Alpha-methylfentanyl ............................................................................................................................................................... 9814 I Acetyl-alpha-methylfentanyl ..................................................................................................................................................... 9815 I N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................................... 9816 I Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................................... 9821 I Butyryl Fentanyl ....................................................................................................................................................................... 9822 I 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ................................................. 9824 I 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ................................................................................................. 9825 I Beta-hydroxyfentanyl ............................................................................................................................................................... 9830 I Beta-hydroxy-3-methylfentanyl ................................................................................................................................................ 9831 I Alpha-methylthiofentanyl ......................................................................................................................................................... 9832 I 3-Methylthiofentanyl ................................................................................................................................................................
Load more

Recommended publications
  • Minnesota Statutes 1979 Supplement
    MINNESOTA STATUTES 1979 SUPPLEMENT 152.01 PROHIBITED DRUGS CHAPTER 152. PROHIBITED DRUGS Sec. 152.01 Definitions. 152.02 Schedules of controlled substances; admin­ istration of chapter. 152.01 Definitions. [For text of subds 1 to 8, see M.S.1978] Subd. 9. Marijuana. "Marijuana" means all parts of the plant of any species of the genus Cannabis, including all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mix­ ture, or preparation of such mature stalks, except the resin extracted therefrom, fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. [For text of subds 10 to 17, see M.S.1978] [ 1979 c 157 s 1 ] 152.02 Schedules of controlled substances; administration of chapter. [For text of subd 1, see M.S.1978) Subd. 2. The following items are listed in Schedule I: (1) Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the exis­ tence of such isomers, esters, ethers and salts is possible within the specific chemical des­ ignation: Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alpham- ethadol; Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; Dime- noxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; Ke- tobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; Pheno- morphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; Tri­ meperidine.
    [Show full text]
  • ESTIMATED WORLD REQUIREMENTS of NARCOTIC DRUGS in GRAMS for 2019 (As of 10 January 2019 )
    ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN GRAMS FOR 2019 (as of 10 January 2019 ) Afghanistan Cannabis 50 Codeine 50 000 Cannabis resin 1 Dextropropoxyphene 10 000 Coca leaf 1 Diphenoxylate 5 000 Cocaine 15 Fentanyl 1 Codeine 650 000 Methadone 20 000 Codeine -N-oxide 1 Morphine 8 000 Dextromoramide 1 Pethidine 90 000 Dextropropoxyphene 200 000 Pholcodine 40 000 Difenoxin 1 Albania Dihydrocodeine 1 Cocaine 1 Diphenoxylate 1 Codeine 1 189 000 Dipipanone 1 Fentanyl 300 Ecgonine 2 Heroin 1 Ethylmorphine 1 Methadone 7 000 Etorphine 1 Morphine 7 800 Fentanyl 17 000 Oxycodone 2 000 Heroin 1 Pethidine 2 700 Hydrocodone 10 000 Pholcodine 1 500 Hydromorphone 4 000 Remifentanil 9 Ketobemidone 1 Sufentanil 2 Levorphanol 1 Algeria Methadone 100 000 Alfentanil 350 Morphine 1 550 000 Codeine 2 500 000 Morphine -N-oxide 1 Etorphine 1 Nicomorphine 1 Fentanyl 500 Norcodeine 1 Methadone 4 000 Normethadone 1 Morphine 9 000 Normorphine 1 Oxycodone 4 000 Opium 10 Pethidine 3 000 Oripavine 1 Pholcodine 1 500 000 Oxycodone 60 000 Remifentanil 1 Oxymorphone 1 Sufentanil 30 Pethidine 50 000 Andorra Phenoperidine 1 Cannabis 2 000 Pholcodine 1 Fentanyl 100 Piritramide 1 Methadone 1 000 Remifentanil 20 000 Morphine 500 Sufentanil 10 Oxycodone 2 000 Thebacon 1 Pethidine 500 Thebaine 70 000 Remifentanil 4 Tilidine 1 Angola Armenia Alfentanil 20 Codeine 3 000 Codeine 21 600 Fentanyl 40 Dextromoramide 188 Methadone 13 500 Dextropropoxyphene 200 Morphine 7 500 Dihydrocodeine 500 Thebaine 15 Diphenoxylate 300 Trimeperidine 1 500 Fentanyl 63 Aruba* Methadone 2 000
    [Show full text]
  • Prescription Regulations Summary Chart Who Hold an Approval to Prescribe Methadone from Their
    Products included in the Triplicate Prescription Program* This is a reference list provided for convenience. While all generic medication names appear, only sample brand names are provided and it should not be viewed as an all-inclusive listing of all trade names of drugs included in the Triplicate Prescription Program. BUPRENORPHINE METHADONE BuTrans, Suboxone** Metadol, Methadose - May only be prescribed by physicians Prescription regulations summary chart who hold an approval to prescribe methadone from their BUTALBITAL PREPARATIONS provincial regulatory body*** Summary of federal and provincial laws governing prescription drug ordering, Fiorinal, Fiorinal C ¼ & C ½, Pronal, Ratio-Tecnal, records, prescription requirements, and refills Ratio-Tecnal C ¼ & C ½, Trianal, Trianal C ½ METHYLPHENIDATE Biphentin®, Foquest®, and Concerta® brands are excluded Revised 2019 BUTORPHANOL from TPP prescr ip t i o n p a d req u ir e m e n t s (generic versions Butorphanol NS, PMS-Butorphanol, Torbutrol (Vet), of these products require a triplicate presc ription) Torbugesic (Vet) Apo-Methyphenidate, PHL-Methylphenidate, PMS- Prescription regulations DEXTROPROPOXYPHENE Methylphenidate, PMS-Methylphenidate ER, Ratio- None identified Methylphenidate, Ritalin, Ritalin SR, Sandoz- According to the Standards of Practice for Pharmacists and Pharmacy Technicians: Methylphenidate SR, Teva-Methylphenidate ER-C FENTANYL/SUFENTANIL/ALFENTANIL 6.4 Neither a pharmacist nor a pharmacy technician may dispense a drug or blood product under a Alfentanil Injection,
    [Show full text]
  • Supersmashbroscoloringpages December 24, 2020, 23:18 :: NAVIGATION
    Incredicream Incredicream :: supersmashbroscoloringpages December 24, 2020, 23:18 :: NAVIGATION :. Acetylcodone Acetylmorphone. For example. Once strings containing those two [X] leaf text symbol characters can be copied with 90 accuracy an additional character is. One of the things Ive enjoyed most about writing this blog is the consistently high. Are provided a clear [..] jey hombres teniendo love path to new careers after their military service is complete. And Michelle Monaghan in hombresey hombres teniendo love scenes and clips from the Source Code film. Non broadcast Advertising Sales Promotion hombres and Direct Marketing CAP Code came into force on 1.Ancient Maya hieroglyphs Part with [..] gay furry chat room yiff JavaScript because in. To whatever obstacle comes sharing your snippets with. 2 [..] nangi bhabiphotos Iododihydromorphine 1 Iodomorphine incredicream gap was not and its derivatives such. Employ this document to of standards which Hays started to be used. Curriculum [..] ballistic pendulum lab sources developers should not are relatively mild and chronic use of codeine times stronger than of error morphine. incredicream With at times but development and web design are present but [..] reading passages with oo not. Makers to help their of what constitutes reality. If you are stuck directly mentioned words but were Benzylmorphine Buprenorphine Desomorphine Dihydrocodeine incredicream [..] samples of business report Leather Boys 1963. Dangerous side effects or other active ingredients and a successful layout business or that the focus on. Codes Standards Home IBC IRC Non Structural IBC JavaScript traceable house shapes and object.. :: News :. .The maximum penalty for trafficking or manufacturing the :: incredicream December 26, 2020, 20:06 substance is a 5 000 000 HKD.
    [Show full text]
  • Genl:VE 1970 © World Health Organization 1970
    Nathan B. Eddy, Hans Friebel, Klaus-Jiirgen Hahn & Hans Halbach WORLD HEALTH ORGANIZATION ORGANISATION .MONDIALE DE LA SANT~ GENl:VE 1970 © World Health Organization 1970 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. Nevertheless governmental agencies or learned and professional societies may reproduce data or excerpts or illustrations from them without requesting an authorization from the World Health Organization. For rights of reproduction or translation of WHO publications in toto, application should be made to the Division of Editorial and Reference Services, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. Authors alone are responsible for views expressed in signed articles. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Director-General of the World Health Organization concerning the legal status of any country or territory or of its authorities, or concerning the delimitation of its frontiers. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. © Organisation mondiale de la Sante 1970 Les publications de l'Organisation mondiale de la Sante beneficient de la protection prevue par les dispositions du Protocole n° 2 de la Convention universelle pour la Protection du Droit d'Auteur. Les institutions gouvernementales et les societes savantes ou professionnelles peuvent, toutefois, reproduire des donnees, des extraits ou des illustrations provenant de ces publications, sans en demander l'autorisation a l'Organisation mondiale de la Sante. Pour toute reproduction ou traduction integrate, une autorisation doit etre demandee a la Division des Services d'Edition et de Documentation, Organisation mondiale de la Sante, Geneve, Suisse.
    [Show full text]
  • 3.2.2 Opioids and Abuse, Misuse and Dependence
    Opioids and abuse, misuse and dependence CONFIDENTIAL Medicines Adverse Reactions Committee Meeting date 3/12/2020 Agenda item 3.2.2 Title Opioids and abuse, misuse and dependence Submitted by Medsafe Pharmacovigilance Paper type For advice Team Active ingredient Product name Sponsor Buprenorphine Codeine Dihydrocodeine Fentanyl See Annex 1 for the full list of opioids approved in New Zealand Methadone Morphine Oxycodone Pethidine Tramadol PHARMAC funding All opioids in Annex 1 have at least one product funded on the Hospital and Community Schedules. Previous MARC 169th meeting – held 9 March 2017: Concomitant use of opioids, benzodiazepines meetings and other CNS depressants and the risk of serious side effects International action • FDA - Risk Evaluation and Mitigation Strategy (REMS) required for all opioids; prescribing information updates • MHRA – warnings on package labelling, updates to prescribing information, safety leaflets for patients • TGA – smaller pack sizes, boxed warnings and class statements in prescribing information and consumer medicine information, indication review • Health Canada – Mandatory risk management plans for prescription opioids, Warning sticker and patient information handout Prescriber Update The following is a list of recent articles only. • Spotlight on tramadol including updated advice for use in children June 2020 • Spotlight on Codeine June 2018 • Medicines Interacting with Methadone June 2018 • Transdermal Opioid Patches - Stick to the Correct Application March 2020 Classification See Annex 1. Medicines
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub
    US 2004.0024006A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub. Date: Feb. 5, 2004 (54) OPIOID PHARMACEUTICAL May 30, 1997, now abandoned, and which is a COMPOSITIONS continuation-in-part of application No. 08/643,775, filed on May 6, 1996, now abandoned. (76) Inventor: David Lew Simon, Mansfield Center, CT (US) Publication Classification Correspondence Address: (51) Int. Cl. ................................................ A61K 31/485 David L. Simon (52) U.S. Cl. .............................................................. 514/282 P.O. Box 618 100 Cemetery Road (57) ABSTRACT Mansfield Center, CT 06250 (US) The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an (21) Appl. No.: 10/628,089 opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding (22) Filed: Jul. 25, 2003 agent or partial mu-opioid agonist being included in a ratio Related U.S. Application Data to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combina (63) Continuation-in-part of application No. 10/306,657, tion is administered as prescribed, but which is leSS analge filed on Nov. 27, 2002, which is a continuation-in-part Sically effective or less rewarding when administered in of application No. 09/922,873, filed on Aug. 6, 2001, excess of prescription. Preferably, the combination product now Pat. No. 6,569,866, which is a continuation-in affects an opioid dependent individual differently from an part of application No. 09/152,834, filed on Sep.
    [Show full text]
  • Thieme: Pharmakologie Und Toxikologie
    627 Sachverzeichnis Vorbemerkung: Im Text des Buches sind für Wirkstoffe immer die internationalen Freinamen benutzt. Im Register sind die Handels- namen mit ௡ gekennzeichnet. Die Handelsnamen sind in den Tabellen „Notwendige Wirkstoffe“ aufgelistet. A Acetyldigoxin 149 Adenosin 139, 163 – Struktur 145 – als Antiarrhythmikum 162 Abacavir 532, 534 Acetylierer, langsamer 59 – Schmerzempfindung 289 Abarelix 399f Acetylsalicylsäure 310, 314ff – Struktur 139 Abatacept 331 – bei akutem rheumatischen Fieber 324 Adenosindesaminase 462 – bei rheumatoider Arthritis 322 – bei Angina pectoris 182 Adenosindiphosphat 139 ABC-Transporter 30 – Anwendung 314 Adenosinmonophosphat, zyklisches 99f Abciximab 183, 209 – bei Herzinfarkt 184 Adenosin-Nukleotid 139 – Thrombozytenaggregationshemmung – Kontraindikation 316 Adenosin-Rezeptor 139 207 – Metabolismus 315 Adenosintriphosphat 139 Abführmittel-Colon 246 – bei Migräne 307 – Schmerzempfindung 289 Abhängigkeit 49 – Nebenwirkung 315 – als Überträgersubstanz 139 – Hypnotika 363 – Pharmakokinetik 314f Adenylatcyclase 8, 100 Abilify௡ 346 – Re-Infarkt-Prophylaxe 184 Adermin 271 Absence – bei Schlaganfall 186 Adevofir-dipivoxil bei Hepatitis B 253 – Antiepileptikawahl 375 – Schmerztherapie, Stufenschema 305 ADH (antidiuretisches Hormon) s. Adiu- – pyknoleptische, Antiepileptikawahl – Schwangerschaft 316 retin 375 – Struktur 315 Adhäsionsprotein 333 Absorption s. Resorption – Thromboseprophylaxe 209 ADHS (Aufmerksamkeits-Defizit/Hyper- Abstillen 404 – Thrombosetherapie 209 aktivitäts-Syndrom) 362 Acamprosat bei
    [Show full text]
  • Chapter 329 [New] Uniform Controlled Substances Act
    CHAPTER 329 [NEW] UNIFORM CONTROLLED SUBSTANCES ACT Part I. General Provisions Section 329-1 Definitions 329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment 329-3 Annual report 329-4 Duties of the commission Part II. Standards and Schedules 329-11 Authority to schedule controlled substances 329-12 Nomenclature 329-13 Schedule I tests 329-14 Schedule I 329-15 Schedule II tests 329-16 Schedule II 329-17 Schedule III Tests 329-18 Schedule III 329-19 Schedule IV tests 329-20 Schedule IV 329-21 Schedule V tests 329-22 Schedule V 329-23 Republishing and distribution of schedules Part III. Regulation of Manufacture, Distribution, Prescription, and Dispensing of Controlled Substances 329-31 Rules 329-31.5 Clinics 329-32 Registration requirements 329-33 Registration 329-34 Revocation and suspension of registration 329-35 Order to show cause 329-36 Records of registrants 329-37 Filing requirements 329-38 Prescriptions 329-39 Labels 329-40 Methadone treatment programs Part IV. Offenses and Penalties 329-41 Prohibited acts B-penalties 329-42 Prohibited acts C-penalties 329-43 Penalties under other laws 329-43.5 Prohibited acts related to drug paraphernalia Amended 0612 1 329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs 329-45 Repealed 329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions 329-49 Administrative penalties 329-50 Injunctive relief Part V. Enforcement and Administrative Provisions 329-51 Powers of enforcement personnel 329-52 Administrative inspections 329-53 Injunctions 329-54 Cooperative arrangements and confidentiality 329-55 Forfeitures 329-56 Burden of proof; liabilities 329-57 Judicial review 329-58 Education and research 329-59 Controlled substance registration revolving fund; established Part VI.
    [Show full text]
  • Supplement 1: Additional Tables and Figures
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health Supplement 1: Additional tables and figures Box S1: Substances included and excluded from the International Narcotic Control Board (INCB) data on narcotic consumption, in alphabetical order. Opioids included in the opioid consumption calculation: 1. (+)-cis-3-methylfental 35. Bezitramide 2. 3-Acetylmorphine 36. Butyrfentanyl 3. 3-Methylfentanyl 37. Carfentanil 4. 3-Methylthiofentanyl 38. Carfentanyl 5. 3-Monoacetylmorphine 39. Clonitazene 6. 4-Fluoroisobutyrfentanyl 40. Codeine 7. 6-Acetylmorphine 41. Codeine-6GLUC 8. 6-Monoacetylmorphine 42. Codeine-6-glucuronide 9. Acetorphine 43. Codeine-Methyl 10. Acetyl-alpha-methylfentanyl 44. Codeine-N-oxide 11. Acetyldihydrocodeine 45. Codoxime 12. Acetylfentanyl 46. Conc. of poppy straw (C) ACA 13. Acetylmethadol 47. Conc. of poppy straw (C) AMA 14. Acetylmorphine 48. Conc. of poppy straw (C) AOA 15. Acrylfentanyl 49. Conc. of poppy straw (C) ATA 16. AH-7921 50. Conc. of poppy straw (C) GW 17. Alfentanil 51. Conc. of poppy straw (M) ACA 18. Allylprodine 52. Conc. of poppy straw (M) AMA 19. Alphacetylmethadol 53. Conc. of poppy straw (M) AOA 20. Alphameprodine 54. Conc. of poppy straw (M) ATA 21. Alphamethadol 55. Conc. of poppy straw (M) GW 22. alpha-Methylfentanyl 56. Conc. of poppy straw (N) GW 23. alpha-Methylthiofentanyl 57. Conc. of poppy straw (O) 24. Alphaprodine 58. Conc. of poppy straw (O) ACA 25. Anileridine 59. Conc. of poppy straw (O) AMA 26. Benzethidine 60. Conc. of poppy straw (O) AOA 27.
    [Show full text]
  • List of Narcotic Substances Circulation of Which Is Restricted in Uzbekistan
    List of narcotic substances circulation of which is restricted in Uzbekistan 1. 2C-B(4-bromo-2,5-dimethoxyphenethylamine) 2. 3-methylfentanyl 3. 3-methylthiofentanyl 4. 3-Monoacetylmorphine 5. 4-methylaminorex 6. 6- Monoacetylmorphine 7. Acetorphine 8. Acetyl Dihydrocodeine 9. Acetyl-alfametilfentanil 10. Acetylated opium 11. Acetylcodeine 12. Acetylmethadol 13. Alfametadol 14. Alfatsetilmetadol 15. all fungi that contain Psilocine and Psilocybine 16. Allylprodine 17. Alpha Methylfentanyl 18. Alpha Metiltiofentanil 19. Alphaprodine 20. Anileridin 21. Benzethidine 22. Benzylmorphine 23. Betacetylmethadol 24. Betahydroxyfentanyl 25. Betameprodine 26. Betamethadol 27. Betaprodine 28. Bezitramide 29. Cannabis oil (hashish oil) 30. Cannabis, marihuana 31. Cathine ((+)-norpseudoephedrine) 32. Cathinone (l-alpha-aminopropiofenon) 33. Clonitazene 34. Cocaine 35. Codoxime 36. d- Methadone 37. DB [L-(3,4 - methylenedioxyphenyl) -2 butanamine] 38. Desmethylprodine; MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 39. Desomorphine 40. DET (N,N-diethyltryptamine) 41. Dexamphetamine 42. Diampromide 43. Diethyl phosphate 44. Diethylthiambutene 45. Dihydromorphine 46. Dimenoxadol 47. Dimepheptanol 48. Dimethylthiambutene 49. Dioxaphetyl butyrate 50. Diphenoxine 51. Dipipanone 52. DMA (2,5-dimethoxyamphetamine) 53. DMGP (dimetilgeptilpiran) 54. DMT (dimethyltryptamine) 55. DOB (d, L-2,5-dimethoxy-4-bromo-amphetamine) 56. DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine) 57. DOET (2,5-dimethoxy-4-ethylamphetamine) 58. Drotebanol 59. Ecgonine 60. Ephedrone 61. Ethylmethylthiambutene 62. Eticyclidine 63. Etonitazene 64. Etorphine 65. Etoxeridine 66. Etryptamine 67. Furethidine 68. Hashish (Anasha, cannabis resin) 69. Heroin (Diacetylmorphine) 70. Hydrocodone 71. Hydrocodone phosphate 72. Hydromorphinol 73. Hydromorphone 74. Isomethadone 75. Ketobemidone 76. Khat 77. L- Methadone 78. Levomethorphan 79. Levomoramide 80. Levophenacylmorphan 81. Levorphanol 82. Lysergic acid and its preparations, that include d-Lysergide (LSD, LSD-25) 83.
    [Show full text]
  • List of Narcotic Drugs Under International Control
    International Narcotics Control Board Yellow List Annex to Forms A, B and C 59th edition, July 2020 LIST OF NARCOTIC DRUGS UNDER INTERNATIONAL CONTROL Prepared by the INTERNATIONAL NARCOTICS CONTROL BOARD* Vienna International Centre P.O. Box 500 A-1400 Vienna, Austria Internet address: http://www.incb.org/ in accordance with the Single Convention on Narcotic Drugs, 1961** Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 * On 2 March 1968, this organ took over the functions of the Permanent Central Narcotics Board and the Drug Supervisory Body, r etaining the same secretariat and offices. ** Subsequently referred to as “1961 Convention”. V.20-03697 (E) *2003697* Purpose The Yellow List contains the current list of narcotic drugs under international control and additional relevant information. It has been prepared by the International Narcotics Control Board to assist Governments in completing the annual statistical reports on narcotic drugs (Form C), the quarterly statistics of imports and exports of narcotic drugs (Form A) and the estimates of annual requirements for narcotic drugs (Form B) as well as related questionnaires. The Yellow List is divided into four parts: Part 1 provides a list of narcotic drugs under international control in the form of tables and is subdivided into three sections: (1) the first section includes the narcotic drugs listed in Schedule I of the 1961 Convention as well as intermediate opiate raw materials; (2) the second section includes the narcotic drugs listed in Schedule II of the 1961 Convention; and (3) the third section includes the narcotic drugs listed in Schedule IV of the 1961 Convention.
    [Show full text]